Market Overview

HCA Announces Proposed Public Offering of Senior Notes


HCA Healthcare, Inc. (NYSE:HCA) today announced that its wholly owned
subsidiary, HCA Inc., proposes to offer $2.0 billion aggregate principal
amount of senior notes, subject to market and other considerations.
Actual terms of the notes, including interest rate and principal amount,
will depend on market conditions at the time of pricing. HCA Inc.
intends to use the net proceeds of this offering for the redemption of
all $1,500,000,000 outstanding aggregate principal amount of HCA Inc.'s
3.75% Senior Secured Notes due 2019 and the payment of related premiums,
and for general corporate purposes, which may include acquisitions.

Goldman Sachs & Co. LLC, Barclays, BofA Merrill Lynch, Citigroup,
Deutsche Bank Securities, J.P. Morgan, Morgan Stanley, RBC Capital
Markets, SMBC Nikko, SunTrust Robinson Humphrey, UBS Investment Bank and
Wells Fargo Securities are acting as the joint book-running managers for
the offering.

The offering of the notes is being made pursuant to an effective shelf
registration statement filed with the Securities and Exchange
Commission. The offering is being made only by means of a preliminary
prospectus supplement and the accompanying prospectus, copies of which
may be obtained from Goldman Sachs & Co. LLC, Prospectus Department, 200
West Street, New York, NY 10282, telephone: 1-866-471-2526, facsimile:
212-902-9316 or by emailing

You may also visit
to obtain an electronic copy of the prospectus and related preliminary
prospectus supplement.

This press release shall not constitute an offer to sell or a
solicitation of an offer to buy, nor shall there be any sale of the
notes in any jurisdiction in which such offer, solicitation or sale
would be unlawful prior to registration or qualification under the
securities laws of any such jurisdiction.


Information provided and statements contained in this press release that
are not purely historical are forward-looking statements within the
meaning of Section 27A of the Securities Act, Section 21E of the
Exchange Act and the Private Securities Litigation Reform Act of 1995.
Such forward-looking statements only speak as of the date of this press
release and HCA assumes no obligation to update the information included
in this press release. Such forward-looking statements include the
expected use of proceeds from the offering. These statements often
include words such as "approximate," "believe," "expect," "anticipate,"
"intend," "plan," "estimate" or similar expressions. These
forward-looking statements are not historical facts, and are based on
current expectations, estimates and projections about HCA's industry,
management's beliefs and certain assumptions made by management, many of
which, by their nature, are inherently uncertain and beyond HCA's
control. Accordingly, readers are cautioned that any such
forward-looking statements are not guarantees of future performance or
occurrence of events and are subject to certain risks, uncertainties and
assumptions that are difficult to predict. Although HCA believes that
the expectations reflected in such forward-looking statements are
reasonable as of the date made, expectations may prove to have been
materially different from the results expressed or implied by such
forward-looking statements. Unless otherwise required by law, HCA also
disclaims any obligation to update its view of any such risks or
uncertainties or to announce publicly the result of any revisions to the
forward-looking statements made in this press release.

All references to the "Company" and "HCA" as used throughout this press
release refer to HCA Healthcare, Inc. and its affiliates.

View Comments and Join the Discussion!